Novartis Reportedly in Talks to Acquire Israeli Stem Cell Developer for up to … – Algemeiner
| Algemeiner Gamida-Cell Ltd. Israel stem cell treatment developer Gamida-Cell Ltd. is in talks to be acquired by Novartis, the pharmaceutical giant, for up to $600 million, according to Israel’s Globes business daily, citing sources familiar with the deal. Gamida … Novartis Trying to Buy Israeli Stem Cell Research DeveloperThe Jewish Press Novartis In Advanced Talks to Acquire Israeli Stem Cell Developer Gamida-CellJewish Business News Novartis AG (ADR) (NVS) news: Novartis in talks to buy stem–cell firm for up …Seeking Alpha Haaretz –Genetic Engineering News –FierceBiotech all 29 news articles |
